Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Competitors & Peer Comparison
See (SNPHY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNPHY | $10.14 | -0.88% | 3.3B | 17.27 | $0.59 | +2.12% |
| BMYMP | $780.50 | -18.70% | 1.9T | 4178.76 | $0.23 | +4.21% |
| RHHBF | $435.61 | -0.20% | 347.5B | 21.19 | $20.60 | +5.66% |
| RHHBY | $50.05 | -3.62% | 323.7B | 19.48 | $2.58 | +1.98% |
| RHHVF | $418.84 | -2.60% | 321.1B | 19.57 | $20.61 | +3.00% |
| AZNCF | $193.31 | -0.86% | 299.7B | 32.06 | $6.03 | +1.62% |
| NVSEF | $151.00 | -4.24% | 288.1B | 21.12 | $7.15 | +3.15% |
| GLAXF | $27.00 | -0.15% | 108.2B | 14.52 | $1.86 | +3.27% |
| SNYNF | $86.90 | +0.22% | 104.9B | 18.73 | $4.64 | +5.07% |
| CHGCF | $59.76 | -0.71% | 98.3B | 36.00 | $1.66 | +3.02% |
Stock Comparison
SNPHY vs BMYMP Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, BMYMP has a market cap of 1.9T. Regarding current trading prices, SNPHY is priced at $10.14, while BMYMP trades at $780.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas BMYMP's P/E ratio is 4178.76. In terms of profitability, SNPHY's ROE is +0.11%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, SNPHY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check BMYMP's competition here
SNPHY vs RHHBF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, RHHBF has a market cap of 347.5B. Regarding current trading prices, SNPHY is priced at $10.14, while RHHBF trades at $435.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas RHHBF's P/E ratio is 21.19. In terms of profitability, SNPHY's ROE is +0.11%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, SNPHY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check RHHBF's competition here
SNPHY vs RHHBY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, RHHBY has a market cap of 323.7B. Regarding current trading prices, SNPHY is priced at $10.14, while RHHBY trades at $50.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas RHHBY's P/E ratio is 19.48. In terms of profitability, SNPHY's ROE is +0.11%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, SNPHY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check RHHBY's competition here
SNPHY vs RHHVF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, RHHVF has a market cap of 321.1B. Regarding current trading prices, SNPHY is priced at $10.14, while RHHVF trades at $418.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas RHHVF's P/E ratio is 19.57. In terms of profitability, SNPHY's ROE is +0.11%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, SNPHY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check RHHVF's competition here
SNPHY vs AZNCF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, AZNCF has a market cap of 299.7B. Regarding current trading prices, SNPHY is priced at $10.14, while AZNCF trades at $193.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas AZNCF's P/E ratio is 32.06. In terms of profitability, SNPHY's ROE is +0.11%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, SNPHY is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check AZNCF's competition here
SNPHY vs NVSEF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, NVSEF has a market cap of 288.1B. Regarding current trading prices, SNPHY is priced at $10.14, while NVSEF trades at $151.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas NVSEF's P/E ratio is 21.12. In terms of profitability, SNPHY's ROE is +0.11%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, SNPHY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check NVSEF's competition here
SNPHY vs GLAXF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, GLAXF has a market cap of 108.2B. Regarding current trading prices, SNPHY is priced at $10.14, while GLAXF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas GLAXF's P/E ratio is 14.52. In terms of profitability, SNPHY's ROE is +0.11%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, SNPHY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check GLAXF's competition here
SNPHY vs SNYNF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, SNYNF has a market cap of 104.9B. Regarding current trading prices, SNPHY is priced at $10.14, while SNYNF trades at $86.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas SNYNF's P/E ratio is 18.73. In terms of profitability, SNPHY's ROE is +0.11%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, SNPHY is less volatile compared to SNYNF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check SNYNF's competition here
SNPHY vs CHGCF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CHGCF has a market cap of 98.3B. Regarding current trading prices, SNPHY is priced at $10.14, while CHGCF trades at $59.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CHGCF's P/E ratio is 36.00. In terms of profitability, SNPHY's ROE is +0.11%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, SNPHY is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check CHGCF's competition here
SNPHY vs CHGCY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CHGCY has a market cap of 96B. Regarding current trading prices, SNPHY is priced at $10.14, while CHGCY trades at $29.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CHGCY's P/E ratio is 35.15. In terms of profitability, SNPHY's ROE is +0.11%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, SNPHY is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check CHGCY's competition here
SNPHY vs BAYRY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, BAYRY has a market cap of 43B. Regarding current trading prices, SNPHY is priced at $10.14, while BAYRY trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas BAYRY's P/E ratio is -10.23. In terms of profitability, SNPHY's ROE is +0.11%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, SNPHY is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check BAYRY's competition here
SNPHY vs OTSKY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, OTSKY has a market cap of 37.4B. Regarding current trading prices, SNPHY is priced at $10.14, while OTSKY trades at $34.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas OTSKY's P/E ratio is 15.79. In terms of profitability, SNPHY's ROE is +0.11%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, SNPHY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check OTSKY's competition here
SNPHY vs OTSKF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, OTSKF has a market cap of 35.9B. Regarding current trading prices, SNPHY is priced at $10.14, while OTSKF trades at $68.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas OTSKF's P/E ratio is 14.05. In terms of profitability, SNPHY's ROE is +0.11%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, SNPHY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check OTSKF's competition here
SNPHY vs DSKYF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, DSKYF has a market cap of 33.3B. Regarding current trading prices, SNPHY is priced at $10.14, while DSKYF trades at $17.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas DSKYF's P/E ratio is 18.95. In terms of profitability, SNPHY's ROE is +0.11%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, SNPHY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check DSKYF's competition here
SNPHY vs DSNKY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, DSNKY has a market cap of 32.6B. Regarding current trading prices, SNPHY is priced at $10.14, while DSNKY trades at $17.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas DSNKY's P/E ratio is 18.53. In terms of profitability, SNPHY's ROE is +0.11%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, SNPHY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check DSNKY's competition here
SNPHY vs ALPMF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, ALPMF has a market cap of 29.3B. Regarding current trading prices, SNPHY is priced at $10.14, while ALPMF trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas ALPMF's P/E ratio is 37.23. In terms of profitability, SNPHY's ROE is +0.11%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, SNPHY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check ALPMF's competition here
SNPHY vs ALPMY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, ALPMY has a market cap of 26.2B. Regarding current trading prices, SNPHY is priced at $10.14, while ALPMY trades at $14.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas ALPMY's P/E ratio is 33.30. In terms of profitability, SNPHY's ROE is +0.11%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, SNPHY is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check ALPMY's competition here
SNPHY vs ORINY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, ORINY has a market cap of 23.1B. Regarding current trading prices, SNPHY is priced at $10.14, while ORINY trades at $41.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas ORINY's P/E ratio is 20.02. In terms of profitability, SNPHY's ROE is +0.11%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, SNPHY is less volatile compared to ORINY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check ORINY's competition here
SNPHY vs CHJTF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CHJTF has a market cap of 15.8B. Regarding current trading prices, SNPHY is priced at $10.14, while CHJTF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CHJTF's P/E ratio is 27.60. In terms of profitability, SNPHY's ROE is +0.11%, compared to CHJTF's ROE of +0.06%. Regarding short-term risk, SNPHY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check CHJTF's competition here
SNPHY vs GIKLY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, GIKLY has a market cap of 14.6B. Regarding current trading prices, SNPHY is priced at $10.14, while GIKLY trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas GIKLY's P/E ratio is 17.38. In terms of profitability, SNPHY's ROE is +0.11%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, SNPHY is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check GIKLY's competition here
SNPHY vs CSPCY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CSPCY has a market cap of 12.5B. Regarding current trading prices, SNPHY is priced at $10.14, while CSPCY trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CSPCY's P/E ratio is 22.68. In terms of profitability, SNPHY's ROE is +0.11%, compared to CSPCY's ROE of +0.06%. Regarding short-term risk, SNPHY is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check CSPCY's competition here
SNPHY vs RCDTF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, RCDTF has a market cap of 11.6B. Regarding current trading prices, SNPHY is priced at $10.14, while RCDTF trades at $56.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas RCDTF's P/E ratio is 25.54. In terms of profitability, SNPHY's ROE is +0.11%, compared to RCDTF's ROE of +0.21%. Regarding short-term risk, SNPHY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check RCDTF's competition here
SNPHY vs ORINF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, ORINF has a market cap of 11.1B. Regarding current trading prices, SNPHY is priced at $10.14, while ORINF trades at $78.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas ORINF's P/E ratio is 19.07. In terms of profitability, SNPHY's ROE is +0.11%, compared to ORINF's ROE of +0.47%. Regarding short-term risk, SNPHY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check ORINF's competition here
SNPHY vs GIFLF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, GIFLF has a market cap of 8.8B. Regarding current trading prices, SNPHY is priced at $10.14, while GIFLF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas GIFLF's P/E ratio is 20.48. In terms of profitability, SNPHY's ROE is +0.11%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, SNPHY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check GIFLF's competition here
SNPHY vs GIFOF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, SNPHY is priced at $10.14, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas GIFOF's P/E ratio is 13.83. In terms of profitability, SNPHY's ROE is +0.11%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, SNPHY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check GIFOF's competition here
SNPHY vs OPHLY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, OPHLY has a market cap of 6.9B. Regarding current trading prices, SNPHY is priced at $10.14, while OPHLY trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas OPHLY's P/E ratio is 21.22. In terms of profitability, SNPHY's ROE is +0.11%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, SNPHY is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check OPHLY's competition here
SNPHY vs OPHLF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, OPHLF has a market cap of 6.6B. Regarding current trading prices, SNPHY is priced at $10.14, while OPHLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas OPHLF's P/E ratio is 19.72. In terms of profitability, SNPHY's ROE is +0.11%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, SNPHY is less volatile compared to OPHLF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check OPHLF's competition here
SNPHY vs KYKOF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, KYKOF has a market cap of 6.5B. Regarding current trading prices, SNPHY is priced at $10.14, while KYKOF trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas KYKOF's P/E ratio is 15.52. In terms of profitability, SNPHY's ROE is +0.11%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, SNPHY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check KYKOF's competition here
SNPHY vs DPHAY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, SNPHY is priced at $10.14, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, SNPHY's ROE is +0.11%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, SNPHY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check DPHAY's competition here
SNPHY vs SNPHF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, SNPHY is priced at $10.14, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas SNPHF's P/E ratio is 18.63. In terms of profitability, SNPHY's ROE is +0.11%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, SNPHY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check SNPHF's competition here
SNPHY vs HAWPF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, HAWPF has a market cap of 3.1B. Regarding current trading prices, SNPHY is priced at $10.14, while HAWPF trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas HAWPF's P/E ratio is 15.07. In terms of profitability, SNPHY's ROE is +0.11%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, SNPHY is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check HAWPF's competition here
SNPHY vs HAWPY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, SNPHY is priced at $10.14, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas HAWPY's P/E ratio is 14.34. In terms of profitability, SNPHY's ROE is +0.11%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, SNPHY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check HAWPY's competition here
SNPHY vs VRBCF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, SNPHY is priced at $10.14, while VRBCF trades at $346.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas VRBCF's P/E ratio is 17.04. In terms of profitability, SNPHY's ROE is +0.11%, compared to VRBCF's ROE of +0.13%. Regarding short-term risk, SNPHY is less volatile compared to VRBCF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check VRBCF's competition here
SNPHY vs PTKFF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, SNPHY is priced at $10.14, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas PTKFF's P/E ratio is N/A. In terms of profitability, SNPHY's ROE is +0.11%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, SNPHY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check PTKFF's competition here
SNPHY vs CMOPF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CMOPF has a market cap of 1.8B. Regarding current trading prices, SNPHY is priced at $10.14, while CMOPF trades at $109.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CMOPF's P/E ratio is 28.24. In terms of profitability, SNPHY's ROE is +0.11%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, SNPHY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check CMOPF's competition here
SNPHY vs LYPHF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, LYPHF has a market cap of 1.5B. Regarding current trading prices, SNPHY is priced at $10.14, while LYPHF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas LYPHF's P/E ratio is 18.88. In terms of profitability, SNPHY's ROE is +0.11%, compared to LYPHF's ROE of +0.03%. Regarding short-term risk, SNPHY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check LYPHF's competition here
SNPHY vs TGRNF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, SNPHY is priced at $10.14, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, SNPHY's ROE is +0.11%, compared to TGRNF's ROE of +0.06%. Regarding short-term risk, SNPHY is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check TGRNF's competition here
SNPHY vs JCRRF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, SNPHY is priced at $10.14, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, SNPHY's ROE is +0.11%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, SNPHY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check JCRRF's competition here
SNPHY vs MAYNF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, MAYNF has a market cap of 153.6M. Regarding current trading prices, SNPHY is priced at $10.14, while MAYNF trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas MAYNF's P/E ratio is -2.39. In terms of profitability, SNPHY's ROE is +0.11%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, SNPHY is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check MAYNF's competition here
SNPHY vs PTKFY Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, PTKFY has a market cap of 13.9M. Regarding current trading prices, SNPHY is priced at $10.14, while PTKFY trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas PTKFY's P/E ratio is 13.52. In terms of profitability, SNPHY's ROE is +0.11%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, SNPHY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check PTKFY's competition here
SNPHY vs PSYGF Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, SNPHY is priced at $10.14, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, SNPHY's ROE is +0.11%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, SNPHY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check PSYGF's competition here
SNPHY vs CRXTQ Comparison March 2026
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.3B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, SNPHY is priced at $10.14, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 17.27, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, SNPHY's ROE is +0.11%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, SNPHY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for SNPHY.Check CRXTQ's competition here